Privia Health Group, Inc. (PRVA)
NASDAQ:PRVA
Want to see PRVA full AI Analyst Report?
PRVA Stock Chart & Stats
$24.02
$0.26(1.28%)
At close: 4:00 PM EST
$24.02
$0.26(1.28%)
Day’s Range― - ―
52-Week Range$18.77 - $26.51
Previous CloseN/A
Volume48.95K
Average Volume (3M)974.23K
Market Cap
$2.62B
Enterprise Value-$407.79B
Total Cash (Recent Filing)$419.52M
Total Debt (Recent Filing)$9.02M
Price to Earnings (P/E)118.7
Beta0.78
Next Earnings
Aug 06, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding126,012,375
10 Day Avg. Volume775,669
30 Day Avg. Volume974,228
Financial Highlights & Ratios
PEG Ratio2.17
Price to Book (P/B)3.93
Price to Sales (P/S)1.36
P/FCF Ratio17.86
Enterprise Value/Market Cap-155.58
Enterprise Value/Revenue-181.52
Enterprise Value/Gross Profit-1.89K
Enterprise Value/Ebitda-7.78K
Forecast
1Y Price Target
$31.18Price Target Upside29.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)0.25
Revenue Forecast (FY)$2.41B
Bulls Say, Bears Say
Bulls Say
Network & Attributed Lives GrowthRapid, sustained growth in implemented providers and attributed lives strengthens Privia’s scale in value‑based care. A larger, diversified provider footprint improves negotiating leverage with payers, increases recurring management fees and shared‑savings potential, and creates durable revenue tailwinds as contracts and patient attribution compound over multiple quarters.
Strong Balance Sheet & Cash Conversion TargetsA cash‑rich, debt‑free balance sheet and a stated high EBITDA→FCF conversion target give Privia financial flexibility. This supports disciplined M&A, technology investment, and weathering timing volatility in shared‑savings payments, reducing refinancing risk and enabling strategic deployment of capital to scale the platform over the medium term.
M&A Momentum And Technology/AI IntegrationAccelerating M&A integration plus proactive tech investment (new CTO, generative AI) can permanently raise operating efficiency and cross‑sell velocity. Successful consolidation increases provider density and care margin leverage, while AI-driven automation of prior auth, coding and chart prep can sustainably lower SG&A per provider and protect long‑term margin expansion.
Bears Say
Thin & Pressured Profit MarginsDespite a return to profitability, low gross and operating margins leave limited cushioning against cost inflation or adverse payer outcomes. Continued margin compression in the TTM suggests pressure from pricing, integration costs or care expenses; thin margins heighten sensitivity of earnings and cash flow to small revenue or utilization shifts over the medium term.
Weaker Recent Free Cash Flow MomentumA meaningful decline in TTM free cash flow and a negative operating cash flow coverage ratio indicate deteriorating cash conversion or timing/working‑capital swings. That reduction constrains organic reinvestment and makes M&A funding more dependent on existing cash balances and execution; it also raises risk if the 80% conversion target is not sustained.
Payer / Policy Contracting UncertaintyStructural shifts in CMS rules (V28) and MA program dynamics create durable contracting uncertainty that can alter risk/reward of value‑based arrangements. Management’s preference for shared‑risk over full capitation limits exposure to upside from capitation while protecting downside, but also may constrain margin capture if payers shift toward capitated models in key markets.
Privia Health Group News
PRVA FAQ
What was Privia Health Group, Inc.’s price range in the past 12 months?
Privia Health Group, Inc. lowest stock price was $18.77 and its highest was $26.51 in the past 12 months.
What is Privia Health Group, Inc.’s market cap?
Privia Health Group, Inc.’s market cap is $2.62B.
When is Privia Health Group, Inc.’s upcoming earnings report date?
Privia Health Group, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 64 days.
How were Privia Health Group, Inc.’s earnings last quarter?
Privia Health Group, Inc. released its earnings results on May 07, 2026. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.075 by -$0.055.
Is Privia Health Group, Inc. overvalued?
According to Wall Street analysts Privia Health Group, Inc.’s price is currently Undervalued.
Does Privia Health Group, Inc. pay dividends?
Privia Health Group, Inc. does not currently pay dividends.
What is Privia Health Group, Inc.’s EPS estimate?
Privia Health Group, Inc.’s EPS estimate is 0.07.
How many shares outstanding does Privia Health Group, Inc. have?
Privia Health Group, Inc. has 126,012,375 shares outstanding.
What happened to Privia Health Group, Inc.’s price movement after its last earnings report?
Privia Health Group, Inc. reported an EPS of $0.02 in its last earnings report, missing expectations of $0.075. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Privia Health Group, Inc.?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.18 (29.82% Upside)
$31.18 (29.82% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 327.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.37%
12-Months-Change
Fundamentals
Return on Equity
0.01%
Trailing 12-Months
Asset Growth
19.80%
Trailing 12-Months
Company Description
Privia Health Group, Inc.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
PRVA Company Deck
PRVA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum — double‑digit provider and attributed‑lives growth, healthy practice collections growth, significant adjusted EBITDA expansion, margin improvement, and successful early integration of Evolent — supported by a large M&A pipeline and clear technology/AI initiatives to drive future efficiency. Offsetting factors included management’s conservative approach to full‑year guidance (except attributed lives), quarter‑to‑quarter volatility from prior‑year adjustments and shared‑savings timing, Q1 seasonality of cash flows, and payer/policy uncertainties (e.g., MA/V28 dynamics and variability in capitated vs. shared‑risk economics). Overall, the positives on growth, profitability, balance sheet flexibility, and execution materially outweighed the cited risks and uncertainties.View all PRVA earnings summariesPRVA Stock 12 Month Forecast
Average Price Target
$31.18
▲(29.82% Upside)
Technical Analysis
Ownership Overview
0.90% Insiders
28.32% Mutual Funds
30.86% Other Institutional Investors
16.94% Public Companies and
Individual Investors